Back
Rate this talk
Your peers rated this 3 stars
3-minute watch | Talk 1 of 1

EU CAR T: Expert Perspective

Secondary malignancies after Car T-cell therapy

Dr Anna Sureda
PERSPECTIVE
EU CAR T

Dr Anna Sureda
Clinical Hematology Department, Institut Català d 'Oncologia L'Hospitalet, Barcelona, Spain

Dr Anna Sureda of Institut Català d'Oncologia, Barcelona, Spain, gives her perspective regarding the risk of secondary malignancies after CAR-T cell therapy and how clinicians should view this when considering CAR T as a treatment option with curative potential for their patients

Read more

Talks in this series

Dr Anna Sureda presents an expert perspective(Secondary malignancies after Car T-cell therapy)
3-minute watch | Talk 1 of 1
EU CAR T: Expert Perspective
Secondary malignancies after Car T-cell therapy
Dr Anna Sureda presents an expert perspective(Secondary malignancies after Car T-cell therapy)
3-minute watch
EU CAR T: Expert Perspective

Secondary malignancies after Car T-cell therapy

Dr Anna Sureda presents an expert perspective(Secondary malignancies after Car T-cell therapy)
3-minute watch | Talk 1 of 1
EU CAR T: Expert Perspective
Secondary malignancies after Car T-cell therapy
Dr Anna Sureda presents an expert perspective(Secondary malignancies after Car T-cell therapy)
3-minute watch
EU CAR T: Expert Perspective

Secondary malignancies after Car T-cell therapy

Interested in this topic?

Find more like this

Suggested for you

Explore suggested content tailored to your role within the CAR T-cell therapy journey

Job code: IHQ-UNB-4903 Date of preparation: October 2023
Job code: IHQ-UNB-4971 Date of preparation: October 2023

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

Reporting of side effects 
If you get any side effects, talk to your doctor or nurse. In Great Britain and Northern Ireland, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.